Qiang Gu
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
Also affiliated: University of British Columbia Hospital (1998–2002); Fujian Medical University (2025); United States Food and Drug Administration (2012–2026); Zhongyuan University of Technology (2026); Tianjin University of Technology (2022); University of British Columbia (1992–2005); Max Planck Society (1993); Army Medical University (2010–2014); Shandong University (2000); Harbin Medical University (2023–2024); Sun Yat-sen University (2023); Queensland University of Technology (2008); China Three Gorges University (2020); Tianjin University (2020–2022); The University of Queensland (2008); Oregon Health & Science University (2018–2026); Nanjing Forestry University (2021); University of Calgary (2000); China Mobile (China) (2018–2024); Jilin University (2007–2013); Nantong University (2022–2023); Peking University (2019); Nankai University (2007); Huawei Technologies (China) (2021); Fudan University (2002); Vancouver Hospital and Health Sciences Centre (2000–2002); China Geological Survey (2024); Ruijin Hospital (2010); Tianjin Medical University General Hospital (2013–2017); Edinburgh Cancer Research (2022); Zhejiang Ocean University (2018–2019); Zhengzhou University (2021); Nantong Maternity and Child Health Hospital (2022–2023); Massachusetts General Hospital (2016); Chongqing Metrology Quality Inspection and Research Institute (2021); Neurolixis (United States) (2025); Jiaxing Vocational Technical College (2025); Schlumberger (Ireland) (2000); Guizhou Electromechanical Research and Design Institute (2019); Xi’an University (2022); Xinqiao Hospital (2010–2024); Fourth Affiliated Hospital of Harbin Medical University (2024); Hangzhou Academy of Agricultural Sciences (2017); Shanghai Electric (China) (2016); Athinoula A. Martinos Center for Biomedical Imaging (2016); Max Planck Institute for Brain Research (1989–1995); First Automotive Works (China) (2014); Peking University First Hospital (2019); Shanghai Fudan Microelectronics (China) (2002); China Ocean Shipping (China) (2025–2026); Shanghai First People's Hospital (2009); Jilin Medical University (2012–2013); Entry Exit Inspection and Quarantine Bureau (2016–2017); Collaborative Innovation Center of Advanced Microstructures (2008–2010); Sinotech Genomics (China) (2015–2017); Zhejiang Entry-Exit Inspection and Quarantine Bureau (2017); Jiangsu University of Technology (2024); Second Affiliated Hospital of Zhejiang University (2017); First Affiliated Hospital of Wannan Medical College (2024–2025); Wake Forest University (2003–2014); Tianjin Medical University (2008–2017); Nagoya University (2018–2020); Sichuan University of Science and Engineering (2022); Zhejiang University (2017–2018); Southeast University (2003); Shandong University of Science and Technology (2015); Auburn University (2010–2016); Nanjing University (2007–2022); University of Science and Technology Beijing (2020–2024)
Faculty Researcher
Upstream record may be merged OpenAlex, the source of these figures, lists 70 institutions in 8 countries for this author record — a pattern that usually means it combines several researchers with similar names. The totals above may include work by other people.
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Qiang Gu's research focuses on understanding disease mechanisms and developing therapeutic strategies across various health conditions. His work has investigated the therapeutic effects and mechanisms of parthenolide in skeletal diseases, cancers, and cytokine storms. Gu has also explored the role of PIM1 in alleviating liver oxidative stress and non-alcoholic fatty liver disease (NAFLD) by regulating the NRF2/HO-1/NQO1 pathway.
His laboratory maintains an active website and leads a research group, collaborating with several researchers at the National Center for Toxicological Research, including Jyotshna Kanungo, Bonnie Robinson, Nathan C. Twaddle, and Frederick A. Beland. Gu has a significant publication record, with 240 total publications and an h-index of 38, reflecting his contributions to the field. He is recognized as a highly cited researcher.
Beyond direct therapeutic research, Gu has also contributed to the development of accessible and reproducible biomedical analysis tools, such as the Galaxy platform and Galaxy-ML, a machine learning toolkit for biomedicine. His publication history also includes work on materials science, such as the preparation of lignin-based epoxy resins and copolymers, and the investigation of lead-free hybrid compounds for solar cell applications.
Metrics
- h-index: 38
- Publications: 243
- Citations: 7,267
Selected Publications
-
N-Acetylcysteine Prevents Arsenic-Induced Apoptosis but Not Supernumerary Motor Neuron Development in Zebrafish Embryos: Assessment of Protein Carbonylation and the p53 Pathway (2026)
-
The effects of cannabidiol and its main metabolites on human neural stem cells (2025)
-
Neurogenic Effects of Inorganic Arsenic and Cdk5 Knockdown in Zebrafish Embryos: A Perspective on Modeling Autism (2024)
-
Gene expression analyses reveal potential mechanism of inorganic arsenic‐induced apoptosis in zebrafish (2023)
-
Combining tissue clearing and Fluoro-Jade C labeling for neurotoxicity assessments (2023)
Collaboration Network
Top Collaborators
- Effect of ketamine on gene expression in zebrafish embryos
- Gene expression analyses reveal potential mechanism of inorganic arsenic‐induced apoptosis in zebrafish
- Neurogenic Effects of Inorganic Arsenic and Cdk5 Knockdown in Zebrafish Embryos: A Perspective on Modeling Autism
- Combining tissue clearing and Fluoro-Jade C labeling for neurotoxicity assessments
- Combining tissue clearing and Fluoro-Jade C labeling for neurotoxicity assessments
- Combining tissue clearing and Fluoro-Jade C labeling for neurotoxicity assessments
- Gene expression analyses reveal potential mechanism of inorganic arsenic‐induced apoptosis in zebrafish
- Gene expression analyses reveal potential mechanism of inorganic arsenic‐induced apoptosis in zebrafish
- Gene expression analyses reveal potential mechanism of inorganic arsenic‐induced apoptosis in zebrafish
- Gene expression analyses reveal potential mechanism of inorganic arsenic‐induced apoptosis in zebrafish
- Gene expression analyses reveal potential mechanism of inorganic arsenic‐induced apoptosis in zebrafish
- Gene expression analyses reveal potential mechanism of inorganic arsenic‐induced apoptosis in zebrafish
- Gene expression analyses reveal potential mechanism of inorganic arsenic‐induced apoptosis in zebrafish
- The effects of cannabidiol and its main metabolites on human neural stem cells
- The effects of cannabidiol and its main metabolites on human neural stem cells
- The effects of cannabidiol and its main metabolites on human neural stem cells
- The effects of cannabidiol and its main metabolites on human neural stem cells
Similar Researchers
Based on overlapping research topics